chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 15.0
Sex: M
Vaccine: HPV4, TDAP, VARCEL
Symptoms: Dizziness, Hyperhidrosis, Loss of consciousness, Muscle tightness, Musculoskeletal stiffness
Clinical narrative: Approximately 15 minutes post vaccination client exhibited tense muscles, crossed feet, hyper-extended neck, loss of consciousness.  This episode lasted approximately 30 seconds.  Post-episode client yelled out loud, became diaphoretic, nauseated and vomited x 4.  Blood pressure, heart rate and temperature within normal limits. Alert and oriented x 3. Approximately 10 minutes later client attempted to stand with assistance but became light headed and nauseated. Client vomited again, very small amount.  Approximately 15 minutes after that client stated he felt 'ok' and was able to stand.  No longer nauseated or diaphoretic. Applied cold compresses to back of neck and forehead.  Stressed to parent the need for immediate follow up care and importance of using emergency services.  Parent insisted on taking client to emergency room herself.  Client did not appear to be in acute distress at this point.  Was escorted, ambulatory, to parents vehicle.  Telephone call referral made to emergency room physician at hospital.
Age: 15.0
Sex: M
Vaccine: HPV4, TDAP, VARCEL
Symptoms: Nausea, Screaming, Vomiting
Clinical narrative: Approximately 15 minutes post vaccination client exhibited tense muscles, crossed feet, hyper-extended neck, loss of consciousness.  This episode lasted approximately 30 seconds.  Post-episode client yelled out loud, became diaphoretic, nauseated and vomited x 4.  Blood pressure, heart rate and temperature within normal limits. Alert and oriented x 3. Approximately 10 minutes later client attempted to stand with assistance but became light headed and nauseated. Client vomited again, very small amount.  Approximately 15 minutes after that client stated he felt 'ok' and was able to stand.  No longer nauseated or diaphoretic. Applied cold compresses to back of neck and forehead.  Stressed to parent the need for immediate follow up care and importance of using emergency services.  Parent insisted on taking client to emergency room herself.  Client did not appear to be in acute distress at this point.  Was escorted, ambulatory, to parents vehicle.  Telephone call referral made to emergency room physician at hospital.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMRV
Symptoms: Pyrexia
Clinical narrative: fever 105 and no other symptoms
Age: 60.0
Sex: M
Vaccine: HEPAB
Symptoms: Urticaria
Clinical narrative: urticaria all over body
Age: 18.0
Sex: M
Vaccine: HPV4
Symptoms: Arthralgia, Borrelia test negative, Chest pain, Cough, Cytomegalovirus test negative
Clinical narrative: GARDASIL #1 11/3/10 - shortly after seen by multi. providers w/dx sinusitis, mycoplasma. Seen in Dec 10 for fatigue, myalgias, chest pain, cough. GARDASIL #2 1/17/11 Pt reported fatigue much worse again in weeks following HPV #2. Also c/o chest pain, arthralgias. Referred to rheum.
Age: 18.0
Sex: M
Vaccine: HPV4
Symptoms: Epstein-Barr virus antibody negative, Fatigue, Laboratory test, Mononucleosis heterophile test negative, Myalgia
Clinical narrative: GARDASIL #1 11/3/10 - shortly after seen by multi. providers w/dx sinusitis, mycoplasma. Seen in Dec 10 for fatigue, myalgias, chest pain, cough. GARDASIL #2 1/17/11 Pt reported fatigue much worse again in weeks following HPV #2. Also c/o chest pain, arthralgias. Referred to rheum.
Age: 18.0
Sex: M
Vaccine: HPV4
Symptoms: Mycoplasma infection, Sinusitis
Clinical narrative: GARDASIL #1 11/3/10 - shortly after seen by multi. providers w/dx sinusitis, mycoplasma. Seen in Dec 10 for fatigue, myalgias, chest pain, cough. GARDASIL #2 1/17/11 Pt reported fatigue much worse again in weeks following HPV #2. Also c/o chest pain, arthralgias. Referred to rheum.
Age: 9.0
Sex: F
Vaccine: HPV4
Symptoms: Epilepsy, Muscular weakness, Pupillary reflex impaired, Syncope
Clinical narrative: Pt fainted at car in clinic parking lot. Mother & sister walked her back into the clinic. We kept her on exam table where she was A & O - VSS. Offered juice. She was taken to ER via w/c d/t c/o (R) arm weakness & sluggish pupils bilat.
Age: 6.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Dyspnoea, Face oedema, Swelling face, Urticaria
Clinical narrative: Initial report received from a health care professional on 21 June 2011. A 6-year-old male patient, medical history unknown, received an intramuscular right deltoid injection of DAPTACEL, sanofi pasteur lot number C3474AA, an intramuscular right deltoid injection of IPOL, sanofi pasteur SA lot number D1086-1, a subcutaneous right tricep injection of MMR, Merck lot number 0832Z, and a subcutaneous left tricep injection of VARICELLA, Merck lot number 1376Z, on 20 June 2011 at 10:30 AM. On 20 June 2011 at 12:10 PM, the patient's parent brought the child back to the physician's office with shortness of breath, facial edema and hives. He was given epinephrine and sent home. The patient returned again at 3:06 PM with lower extremity hives and facial swelling. He was again given epinephrine and sent home after 45 minutes. The outcome was reported as unknown. Documents held by sender: None.
Age: 57.0
Sex: F
Vaccine: FLU3, HEPAB, IPV, MEN, TYP, YF
Symptoms: Herpes zoster, Rash
Clinical narrative: Per client phone call, developed a rash on neck extending to ear and face with onset approx 10 days after vaccines administered. Diagnosis by physician as "shingles" - Rx Acyclovir & VICODIN. Acyclovir ordered tid x 7 days/VICODIN as needed and then switched to MOTRIN. Discussed with clinic physician. Suggested follow-thru with VAERS. Pt notified of such.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site urticaria, Oedema peripheral, Rash, Sunburn, Swelling
Clinical narrative: Developed few discrete hives arms, legs around 9-10 pm: 6/24/11. Advised BENADRYL 25mg every 4-6 hours. Mom called approximately 10-10:30 AM following morning with "sunburn rash, sl. puffiness hands/feet - urticaria spreading to face/torso -> advised ER. Rx prednisone x4 days.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Urticaria
Clinical narrative: Developed few discrete hives arms, legs around 9-10 pm: 6/24/11. Advised BENADRYL 25mg every 4-6 hours. Mom called approximately 10-10:30 AM following morning with "sunburn rash, sl. puffiness hands/feet - urticaria spreading to face/torso -> advised ER. Rx prednisone x4 days.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Erythema, Oedema peripheral
Clinical narrative: Large >10 cm oval area of edema & erythema (L) lateral aspect arm with 1-2 mm vesiculation in center. No fever. Treated with MOTRIN. Local care & cephalexin r/o cellulitis.
Age: 4.0
Sex: M
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: 4 yo male received PREVNAR 13 on 27 Jun 2011. On 29 Jun started having redness/swelling in (L) thigh (whole thigh) where received vaccine. Was swollen and hard. Was given MOTRIN and seen next day at doctor office. Swelling/redness has decreased. Getting better. Pt has h/o complete PCV-7 series with last dose in 10/2007.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site swelling
Clinical narrative: Swelling of right deltoid, went to ER got RX for Septra
Age: 29.0
Sex: F
Vaccine: HEPA, TDAP
Symptoms: Pain, Pain in extremity, Sleep disorder
Clinical narrative: Severe arm pain, exacerbated by movement. Pain 3/10 at rest, 7/10 with movement. Pain so severe that it inhibited sleep.
Age: 23.0
Sex: F
Vaccine: HEP, VARCEL
Symptoms: Injection site induration, Injection site swelling, Pyrexia
Clinical narrative: fever and swelling at injection site   hard area   approx  40 mm in size
Age: 6.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Erythema, Pain
Clinical narrative: 3" x 3" redness and soreness noted 06/17/2011.
Age: 1.3
Sex: M
Vaccine: DTAP, HIBV, PPV
Symptoms: Differential white blood cell count, Full blood count, Haematocrit, Haemoglobin, Lymphocyte percentage decreased
Clinical narrative: Child had 15-20 second episode of tonic seizure activity with 40 minute post-ictal episode. Child had fever to 105.5 AX, did have brief vomiting and chest congestion.  No diarrhea. Family members had similar illness symptoms, also older sibling had history of febrile seizures.
Age: 1.3
Sex: M
Vaccine: DTAP, HIBV, PPV
Symptoms: Neutrophil percentage, Platelet count, Postictal state, Pyrexia, Respiratory tract congestion
Clinical narrative: Child had 15-20 second episode of tonic seizure activity with 40 minute post-ictal episode. Child had fever to 105.5 AX, did have brief vomiting and chest congestion.  No diarrhea. Family members had similar illness symptoms, also older sibling had history of febrile seizures.
Age: 1.3
Sex: M
Vaccine: DTAP, HIBV, PPV
Symptoms: Tonic convulsion, Vomiting, White blood cell count
Clinical narrative: Child had 15-20 second episode of tonic seizure activity with 40 minute post-ictal episode. Child had fever to 105.5 AX, did have brief vomiting and chest congestion.  No diarrhea. Family members had similar illness symptoms, also older sibling had history of febrile seizures.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Abasia, Injection site cellulitis
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of injection site cellulitis in a 5-year-old female subject who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMR vaccine (non-gsk) ;Merck given on 14 June 2011; varicella virus vaccine (non-gsk) ;Merck given on 14 June 2011. On 14 June 2011 at 16:56 the subject received 2nd dose of KINRIX (.5 ml, unknown route, left thigh). On 14 June 2011, less than one day after vaccination with KINRIX, the subject experienced injection site cellulitis. The healthcare professional reported that the subject was not able to walk. The healthcare professional considered the event was clinically significant (or requiring intervention). The subject was treated with KEFLEX. At the time of reporting the outcome of the event was unspecified.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Injection site induration, Pain in extremity
Clinical narrative: On 6-30-11, c/o left arm hurting. Mother reports upper left arm is "hard to the touch." No fever. No redness or swelling noted. Plans to give anti-inflammatory med today. Encouraged movement of arm, cool pack to area. If condition worsens, recommend to contact PMD.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Fatigue, Malaise
Clinical narrative: Client states she felt light-headed and tired the day of vaccine administration.  The day after, she feels very tired, denies light-headedness, states that she felt just kind of sick.  Client also states she is currently on prednisone 20 mg (5 day treatment).
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Bloody discharge, Erythema, Induration, Injection site discharge, Injection site erythema
Clinical narrative: Left arm began to turn red, swell, and drain the morning after vaccine administration as per father of child. Child complains of pain and pruritis. Large area of redness, induration with central sluffing of skin, weeping serosangious fluid, mild necrotic flap tissue. Whole wound semicircular, at widest wound is 13cm by 12cm. Discussed pt received MMR & varicella vaccine at 1yro. Dad denies any reaction. Pt receives flu vaccine annually w/o complications. No hx of allergy to egg. No family hx of allergy to eggs. Discussed with father 3 vaccines were given in L arm due pt's resistance to cooperate during administration of vaccines. Dad admits that pt was noncompliant, she was crying, screaming and thrashing while receiving vaccines. Previous vaccines from previous PCP were pulled to determine no prior reaction to vaccine ever documented.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site swelling, Pain, Pruritus, Secretion discharge, Skin exfoliation
Clinical narrative: Left arm began to turn red, swell, and drain the morning after vaccine administration as per father of child. Child complains of pain and pruritis. Large area of redness, induration with central sluffing of skin, weeping serosangious fluid, mild necrotic flap tissue. Whole wound semicircular, at widest wound is 13cm by 12cm. Discussed pt received MMR & varicella vaccine at 1yro. Dad denies any reaction. Pt receives flu vaccine annually w/o complications. No hx of allergy to egg. No family hx of allergy to eggs. Discussed with father 3 vaccines were given in L arm due pt's resistance to cooperate during administration of vaccines. Dad admits that pt was noncompliant, she was crying, screaming and thrashing while receiving vaccines. Previous vaccines from previous PCP were pulled to determine no prior reaction to vaccine ever documented.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Skin flap necrosis
Clinical narrative: Left arm began to turn red, swell, and drain the morning after vaccine administration as per father of child. Child complains of pain and pruritis. Large area of redness, induration with central sluffing of skin, weeping serosangious fluid, mild necrotic flap tissue. Whole wound semicircular, at widest wound is 13cm by 12cm. Discussed pt received MMR & varicella vaccine at 1yro. Dad denies any reaction. Pt receives flu vaccine annually w/o complications. No hx of allergy to egg. No family hx of allergy to eggs. Discussed with father 3 vaccines were given in L arm due pt's resistance to cooperate during administration of vaccines. Dad admits that pt was noncompliant, she was crying, screaming and thrashing while receiving vaccines. Previous vaccines from previous PCP were pulled to determine no prior reaction to vaccine ever documented.
Age: 13.0
Sex: F
Vaccine: HEPA, HPV4, IPV
Symptoms: Blood pressure decreased, Dizziness, Immediate post-injection reaction, Vaccination site pain
Clinical narrative: Immediately following administration of HPV Vacine Pt complained of feeling dizzy, laid down flat and complained of pain at vaccine site. BP dropped for several minutes following. Pt given smelling salts to smell, Gatorade orally and monitored in reverse Trundelberg position for several minutes.
Age: 69.0
Sex: M
Vaccine: PPV
Symptoms: Chills, Oedema, Pain in extremity, Pyrexia, Vomiting
Clinical narrative: Rt arm pain, vomiting, febrile, edema and chills.
Age: 87.0
Sex: M
Vaccine: VARZOS
Symptoms: Pruritus, Rash
Clinical narrative: Diffuse abdominal itching/rash.
Age: 19.0
Sex: F
Vaccine: MNQ
Symptoms: Blood glucose normal, Dehydration, Loss of consciousness, Somnolence, Syncope
Clinical narrative: Patient was administered Meningococcal vaccine. About 15 minutes later, when exit the store, the patient lost consciousness. Patient regained consciousness quickly was able to answer question, but felt sleepy. Pulse 60 beat per minute. EMS arrived at store and look patient.
Age: 0.5
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PPV, RVX
Symptoms: Injection site erythema, Injection site rash, Injection site urticaria, Urticaria
Clinical narrative: Patient had small red dots around injection site on the evening of June 29, 2011. On the morning of June 30, 2011 she had hives on her thighs, legs, feet and back. Contacted the Dr. on June 30, 2011 and started her on Benadryl. The hives have not cleared up/stopped as of now.
Age: 1.13
Sex: M
Vaccine: HIBV, MMR, PNC13, VARCEL
Symptoms: Body temperature increased, Injection site erythema, Injection site rash
Clinical narrative: Temp elevated 104.5 after vaccinations per mom. Afebrile now. "Red spots" on (R) leg. No treatment given - cool compress prn.
Age: 1.13
Sex: M
Vaccine: HIBV, MMR, PNC13, VARCEL
Symptoms: Body temperature increased, Injection site erythema
Clinical narrative: Temp increased 104.5 after vaccines per mom. Afebrile now "red" spots on (R) leg. No treatment given. Cool compress prn.
Age: 40.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Full blood count abnormal, Lymphadenopathy, Lymphocyte count, Neutrophil count, Type III immune complex mediated reaction
Clinical narrative: W/i 12 hrs of getting vaccine, patient developed an arthus reaction (local vasculitis) & swollen lymph nodes. Urgent Care treated w/KEFLEX for possible cellulitis. Dr. gave Prednisone 20 mg BID x 5 days.
Age: 40.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Vasculitis, White blood cell count
Clinical narrative: W/i 12 hrs of getting vaccine, patient developed an arthus reaction (local vasculitis) & swollen lymph nodes. Urgent Care treated w/KEFLEX for possible cellulitis. Dr. gave Prednisone 20 mg BID x 5 days.
Age: 42.0
Sex: F
Vaccine: TDAP
Symptoms: Musculoskeletal stiffness, Myalgia, Neck pain
Clinical narrative: Pt. complains of muscle pain, stiffness and pain in neck for 13 days after injection given. Possible adverse reaction.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Back pain, Dizziness, Headache, Injection site pain, Pyrexia
Clinical narrative: Fever overnight with headache, lower back pain, dizziness and pain in area of injection site of both upper arms.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Convulsion, Muscle twitching, Unresponsive to stimuli
Clinical narrative: Seizure, 20 seconds, twitching, unresponsive, subsided on its own, pt assessed by MD, sent home.
Age: 61.0
Sex: F
Vaccine: PPV, TDAP, VARZOS
Symptoms: Chills, Erythema, Full blood count normal, Local swelling, Pain
Clinical narrative: Fever and chills, large red and swollen area on arm, approx 7 inches long x 6 inches wide. Painful and swollen, growing.
Age: 61.0
Sex: F
Vaccine: PPV, TDAP, VARZOS
Symptoms: Pyrexia
Clinical narrative: Fever and chills, large red and swollen area on arm, approx 7 inches long x 6 inches wide. Painful and swollen, growing.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Injection site erythema, Injection site vesicles
Clinical narrative: Pt. woke up on 6/26/11 w/redness & small blisters around injection site. Then 06/29/11 she developed a couple large blisters under arm where injection was given. Contacted Merck (guidelines) told pt to contact primary care physician. Pt. described as itchy. It did not hurt.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Dizziness, Pallor, Presyncope, Tremor
Clinical narrative: After HPV sig vasovagal reaction with dizzy, pale BP 88/58 while sitting shaking; lied down resolved w/in 5-10 min BP 115/78.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, PNC13
Symptoms: Urticaria
Clinical narrative: Pt was given DTaP, IPV, MMR, PCV-13 and Tuberculin skin test. Pt returned an estimated hour after receiving vaccines with hives all over the body. We gave him a shot of epi and a dose of BENADRYL.
Age: 41.0
Sex: F
Vaccine: HEP, TDAP
Symptoms: Erythema, Feeling hot, Flushing
Clinical narrative: Reddened area expanding on (R) arm with feeling flushed & area hot.
Age: 29.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: 3" x 5" increasing in size reddened & raised area on left upper deltoid.
Age: 4.0
Sex: F
Vaccine: DTAPIPVHIB, MMR, PNC13, VARCEL
Symptoms: Eyelid oedema, Ocular hyperaemia, Pruritus, Throat irritation
Clinical narrative: Pt. started scratching/itching, eyes puffy and red, c/o scratchy throat. Pt. given 0.15 EPIPEN JR. and 12.5 mg BENADRYL po. BENADRYL repeated 20 min later. Due to epi admitted for observation.
Age: 81.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site discolouration, Injection site movement impairment, Mobility decreased, Skin discolouration
Clinical narrative: This case was reported by a consumer (the patient) and described the occurrence of injection site movement impairment in a 81-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. The subject's medical history included basal cell carcinoma on right arm and breast cancer. Concurrent medications included SYNTHROID, LOPID, and ASA. On 1 October 2009 at 10:00 the subject received unspecified dose of FLUARIX (unknown route, right arm). On 1 October 2009, within 2 hours of vaccination with FLUARIX, the subject experienced injection site movement impairment and injection site discoloration. Her right arm turned black and blue and she could not bend her right arm back at all. At the time of reporting the events were unresolved, the subject was still unable to bend her arm back. The vaccination course with FLUARIX was discontinued. This case was also reported as a pharmaceutical product complaint. The consumer reported that 3 other subjects at the hospital where she received the vaccination experienced the same problem, but that her symptoms have outlasted theirs (see case IDs A0863108A, A0863114A, A0863115A for the other reports). Follow-up received 18 June 2010: QA analysis revealed the complaint to be unsubstantiated. An investigational report was received via GlaxoSmithKline quality assurance on 30 June 2010. It was reported that no sample was returned for testing. No other complaints have been recorded for this batch. This complaint was considered as not verified.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Diarrhoea, Hyperhidrosis, Increased upper airway secretion, Muscular weakness
Clinical narrative: This case was reported by a consumer and described the occurrence of coughing phlegm in a 51-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included fibromyalgia. Concurrent medications included Morphine. On 15 October 2010 at 10:15 the subject received a dose of FLUARIX at 0.5 ml in the left arm. On 15 October 2010, less than one day after vaccination with FLUARIX, the subject experienced coughing phlegm, vomiting and diarrhea. One day later, on 16 October 2010, the subject experienced muscle weakness and decreased muscle strength. Sweating and muscle pain were also reported. Coughing phlegm was reported to be improved, diarrhea resolved on 22 October 2010 and vomiting resolved on 24 October 2010. Muscle strength and weakness was unresolved.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Myalgia, Productive cough, Vomiting
Clinical narrative: This case was reported by a consumer and described the occurrence of coughing phlegm in a 51-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included fibromyalgia. Concurrent medications included Morphine. On 15 October 2010 at 10:15 the subject received a dose of FLUARIX at 0.5 ml in the left arm. On 15 October 2010, less than one day after vaccination with FLUARIX, the subject experienced coughing phlegm, vomiting and diarrhea. One day later, on 16 October 2010, the subject experienced muscle weakness and decreased muscle strength. Sweating and muscle pain were also reported. Coughing phlegm was reported to be improved, diarrhea resolved on 22 October 2010 and vomiting resolved on 24 October 2010. Muscle strength and weakness was unresolved.
Age: 0.3
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5, RV5, DTAPIPVHIB, PNC13, RV5
Symptoms: Apnoeic attack, Condition aggravated, Death, Endotracheal intubation, Hypopnoea
Clinical narrative: Initial report was received on 24 June 2011 from another manufacturer, report number WAERS 1106USA01081. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Information has been received from a physician concerning a 14 week old male patient with medical history of premature birth, congenital heart and lung disease and reflux and with no drug reaction/allergies who on 23-Feb-2011 was vaccinated orally with the first dose of ROTATEQ. Concomitant medications included: ZANTAC and vitamins (unspecified) (POLY-VI-SOL). The patient spit half the first dose out. On 24-Feb-2011 the patient died at home. It was unknown if the patient had sought medical attention. No specified treatment was given to the patient. There was no lab diagnostic test performed. The information about the lot number and the cause of death were unknown. Follow-up information has been received from the physician concerning the 14 week old male patient with no drug reaction/allergies and medical history of premature birth (born at 25 weeks gestation), congenital heart and lung disease, reflux and a diagnosis of chronic dermatitis who on 23-FEB-2011 was vaccinated orally with the first dose of ROTATEQ (lot number 669071/1269Z) (dosing delay due to pre-maturity). Concomitant vaccines included: PREVNAR13 (lot number 915704) and PENTACEL (lot number C3815AA). During the night baby went into respiratory arrest and was rushed to the emergency and died in emergency room (rather than at home as was previously reported) on 24-FEB-2011. An autopsy was performed but the physician said the results were with the legal department and the death certificate also with legal department so the physician could not provided a cause of death. The physician felt that the death was not related to the ROTATEQ vaccine. Upon internal review, respiratory arrest was considered to be an other important medical event. Additional information has been requested. A preliminary lot check investigation was performed. To date our investigation has found that this lot conformed to quality release parameters and the manufacturing was typical of a lot of ROTATEQ. Additional information will be provided upon finalization of this manufacturing investigation." Documents held by sender: none.
Age: 0.3
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5, RV5, DTAPIPVHIB, PNC13, RV5
Symptoms: Pulse absent, Respiratory rate decreased, Resuscitation, Vomiting
Clinical narrative: Initial report was received on 24 June 2011 from another manufacturer, report number WAERS 1106USA01081. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Information has been received from a physician concerning a 14 week old male patient with medical history of premature birth, congenital heart and lung disease and reflux and with no drug reaction/allergies who on 23-Feb-2011 was vaccinated orally with the first dose of ROTATEQ. Concomitant medications included: ZANTAC and vitamins (unspecified) (POLY-VI-SOL). The patient spit half the first dose out. On 24-Feb-2011 the patient died at home. It was unknown if the patient had sought medical attention. No specified treatment was given to the patient. There was no lab diagnostic test performed. The information about the lot number and the cause of death were unknown. Follow-up information has been received from the physician concerning the 14 week old male patient with no drug reaction/allergies and medical history of premature birth (born at 25 weeks gestation), congenital heart and lung disease, reflux and a diagnosis of chronic dermatitis who on 23-FEB-2011 was vaccinated orally with the first dose of ROTATEQ (lot number 669071/1269Z) (dosing delay due to pre-maturity). Concomitant vaccines included: PREVNAR13 (lot number 915704) and PENTACEL (lot number C3815AA). During the night baby went into respiratory arrest and was rushed to the emergency and died in emergency room (rather than at home as was previously reported) on 24-FEB-2011. An autopsy was performed but the physician said the results were with the legal department and the death certificate also with legal department so the physician could not provided a cause of death. The physician felt that the death was not related to the ROTATEQ vaccine. Upon internal review, respiratory arrest was considered to be an other important medical event. Additional information has been requested. A preliminary lot check investigation was performed. To date our investigation has found that this lot conformed to quality release parameters and the manufacturing was typical of a lot of ROTATEQ. Additional information will be provided upon finalization of this manufacturing investigation." Documents held by sender: none.
Age: 0.3
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5, RV5, DTAPIPVHIB, PNC13, RV5
Symptoms: Autopsy, Death, Regurgitation, Respiratory arrest
Clinical narrative: Initial report was received on 24 June 2011 from another manufacturer, report number WAERS 1106USA01081. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Information has been received from a physician concerning a 14 week old male patient with medical history of premature birth, congenital heart and lung disease and reflux and with no drug reaction/allergies who on 23-Feb-2011 was vaccinated orally with the first dose of ROTATEQ. Concomitant medications included: ZANTAC and vitamins (unspecified) (POLY-VI-SOL). The patient spit half the first dose out. On 24-Feb-2011 the patient died at home. It was unknown if the patient had sought medical attention. No specified treatment was given to the patient. There was no lab diagnostic test performed. The information about the lot number and the cause of death were unknown. Follow-up information has been received from the physician concerning the 14 week old male patient with no drug reaction/allergies and medical history of premature birth (born at 25 weeks gestation), congenital heart and lung disease, reflux and a diagnosis of chronic dermatitis who on 23-FEB-2011 was vaccinated orally with the first dose of ROTATEQ (lot number 669071/1269Z) (dosing delay due to pre-maturity). Concomitant vaccines included: PREVNAR13 (lot number 915704) and PENTACEL (lot number C3815AA). During the night baby went into respiratory arrest and was rushed to the emergency and died in emergency room (rather than at home as was previously reported) on 24-FEB-2011. An autopsy was performed but the physician said the results were with the legal department and the death certificate also with legal department so the physician could not provided a cause of death. The physician felt that the death was not related to the ROTATEQ vaccine. Upon internal review, respiratory arrest was considered to be an other important medical event. Additional information has been requested. A preliminary lot check investigation was performed. To date our investigation has found that this lot conformed to quality release parameters and the manufacturing was typical of a lot of ROTATEQ. Additional information will be provided upon finalization of this manufacturing investigation." Documents held by sender: none.
Age: 0.3
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5, RV5, DTAPIPVHIB, PNC13, RV5
Symptoms: Autopsy, Death, Respiratory arrest
Clinical narrative: Initial report was received on 24 June 2011 from another manufacturer, report number WAERS 1106USA01081. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Information has been received from a physician concerning a 14 week old male patient with medical history of premature birth, congenital heart and lung disease and reflux and with no drug reaction/allergies who on 23-Feb-2011 was vaccinated orally with the first dose of ROTATEQ. Concomitant medications included: ZANTAC and vitamins (unspecified) (POLY-VI-SOL). The patient spit half the first dose out. On 24-Feb-2011 the patient died at home. It was unknown if the patient had sought medical attention. No specified treatment was given to the patient. There was no lab diagnostic test performed. The information about the lot number and the cause of death were unknown. Follow-up information has been received from the physician concerning the 14 week old male patient with no drug reaction/allergies and medical history of premature birth (born at 25 weeks gestation), congenital heart and lung disease, reflux and a diagnosis of chronic dermatitis who on 23-FEB-2011 was vaccinated orally with the first dose of ROTATEQ (lot number 669071/1269Z) (dosing delay due to pre-maturity). Concomitant vaccines included: PREVNAR13 (lot number 915704) and PENTACEL (lot number C3815AA). During the night baby went into respiratory arrest and was rushed to the emergency and died in emergency room (rather than at home as was previously reported) on 24-FEB-2011. An autopsy was performed but the physician said the results were with the legal department and the death certificate also with legal department so the physician could not provided a cause of death. The physician felt that the death was not related to the ROTATEQ vaccine. Upon internal review, respiratory arrest was considered to be an other important medical event. Additional information has been requested. A preliminary lot check investigation was performed. To date our investigation has found that this lot conformed to quality release parameters and the manufacturing was typical of a lot of ROTATEQ. Additional information will be provided upon finalization of this manufacturing investigation." Documents held by sender: none.
Sex: U
Vaccine: DTAPIPVHIB
Symptoms: Anaemia, Neutropenia
Clinical narrative: Initial report was received 27 June 2011 from a health care professional. An unidentified patient had received PENTACEL (lot number, route, site and date of administration were unknown) and an unspecified amount of time later, developed neutropenia and anemia. It was unknown if the patient received any other vaccines within four weeks of PENTACEL. Past medical history, concomitant medications, and laboratory/diagnostic testing were reported as unknown. Outcome was not reported. Documents held by sender: None.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Coma
Clinical narrative: Information has been received from a physician concerning a 12 year old female patient, who in 2010, was vaccinated with the first dose of GARDASIL (Lot #, dose and route not reported). Physician stated that during an educational program in a nearby school, the patient approached her to relate her experience after receiving the first GARDASIL injection. The patient fell into a coma-like state and was hospitalized for treatment (date unspecified). Physician reported that the reaction occurred within an hour of the injection. It was reported that the therapy was discontinued and the patient was not reintroduced. At the time of the report, the patient's outcome was recovered (unspecified date). The office contacted during telephone follow-up could not supply the following information: patient name, date of birth, date of vaccination, lot number, date of event, hospital name, and healthcare provider name and contact information. Additional information is not expected.
Age: 1.02
Sex: M
Vaccine: HEP, MMR, PNC13, VARCEL
Symptoms: Allergy test, Blood immunoglobulin E normal, Full blood count normal, Urticaria
Clinical narrative: Pt developed urticarial rash on 6-23-11 around noon time. Pt was seen in the office around 3:35pm. On examination pt had multiple urticarial lesions on the extremities, face, ear & neck. Was sent home on PO BENADRYL with no improvement. Pt was seen in the ER on 6-23-11 at night. Was sent home on ORAPRED & BENADRYL. As pt did not improve, he was hospitalized from 6-24-11 to 6-27-11 & was placed on PO ORAPRED and PO ATARAX. Pt improved. Ped ID was consulted. Pt still on PO ORAPRED (total x 7 days) and PO ATARAX (total x 2 weeks).
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Hypoaesthesia, Immediate post-injection reaction, Loss of consciousness, Mobility decreased
Clinical narrative: Pt administered HPV #2. At approximately 1:20 pm immediately after vaccine administered this pt passed out BP = 88/58 P=88. C/O vaccinated (R) arm. Being numbed and unable to move her fingers. BP = 98/58 at 1:30 PM. Pt spoke with staff.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Convulsion, Pyrexia
Clinical narrative: Patient received 2mos vaccinations on 6/21/11 at 8:30 am. Went to the ER on 6/21/11 at 1:00 with complaint of seizure lasting about one minute fever of 101. Patient was admitted for observation.
Age: 29.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Injected limb mobility decreased, Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: 6/22/11 given PNEUMOVAX 23 IM in (R) delt; increasing pain, redness, swelling, fever 101.5, decreased mobility of arm. Seen at provider, continued to worsen, went to E.D. admitted for IV Abx.
Age: 29.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Ultrasound scan normal, White blood cell count, X-ray normal
Clinical narrative: 6/22/11 given PNEUMOVAX 23 IM in (R) delt; increasing pain, redness, swelling, fever 101.5, decreased mobility of arm. Seen at provider, continued to worsen, went to E.D. admitted for IV Abx.
Age: 14.0
Sex: M
Vaccine: HPV4
Symptoms: Abdominal pain, Blood amylase, Hepatic steatosis, Lipase, Pancreatitis
Clinical narrative: Pancreatitis, lipase 9,800 on 6-12-11 abdominal pain, vomiting.
Age: 14.0
Sex: M
Vaccine: HPV4
Symptoms: Ultrasound liver abnormal, Vomiting
Clinical narrative: Pancreatitis, lipase 9,800 on 6-12-11 abdominal pain, vomiting.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Anosmia, Rash
Clinical narrative: Rash between thighs and on trunk very next day. Over 1 week time, lost sense of smell entirely. Has not regained sense of smell (> 2 months). Physician has placed pt on Cortisone nasal spray w/no change yet.
Age: 1.04
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Irritability, Pyrexia, Rash generalised, Rash papular
Clinical narrative: Full-body red papular rash 9 days after vaccination. Fussy, fever x 1 day.
Age: 13.0
Sex: M
Vaccine: HEPA
Symptoms: Dysphagia, Dyspnoea, Full blood count, Lip swelling, Pharyngeal oedema
Clinical narrative: 6/21/11 4pm received Hep A shot in office 10pm - started w/tightening/swelling of lips and throat. 6/22/11 4AM -administered BENADRYL for rash on face difficulty breathing, swallowing - fever 101.8 - lips swollen. 6/22/11 10:00AM visit to doctor office, rash on forehead and face "still felt throat swollen". CBC done, pulse ox done, started on prednisone 20mg tablet 3 tablets once daily x 4 days.
Age: 13.0
Sex: M
Vaccine: HEPA
Symptoms: Pyrexia, Rash, Skin tightness, Throat tightness, White blood cell count increased
Clinical narrative: 6/21/11 4pm received Hep A shot in office 10pm - started w/tightening/swelling of lips and throat. 6/22/11 4AM -administered BENADRYL for rash on face difficulty breathing, swallowing - fever 101.8 - lips swollen. 6/22/11 10:00AM visit to doctor office, rash on forehead and face "still felt throat swollen". CBC done, pulse ox done, started on prednisone 20mg tablet 3 tablets once daily x 4 days.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Blood culture, Crying, Pyrexia, Rash
Clinical narrative: Per mother child received vaccines 6/22/11 at 2:30pm and about 2:00 am 6/23/11 developed fever 104.5 and was crying inconsolably. Parents took child to hospital, on admission to ED fever 104. No rash at that time. Rash developed 6/24/11 early AM.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: Erythema, pruritus & swelling about 8 hrs after vaccine. Improved without tx over 48 hrs.
Age: 29.0
Sex: M
Vaccine: HEPAB, IPV, MMR, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Pt. developed redness, pain & swelling of left upper arm, for which he sought care in ER on day #3 post-vaccinations. He received pain medication and antibiotic script.
Age: 73.0
Sex: M
Vaccine: PPV
Symptoms: Pain in extremity
Clinical narrative: Injection site left deltoid. Patient said 2 hours after injection arm hurt so bad they went to the ER.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, PNC13, VARCEL
Symptoms: Injection site erythema
Clinical narrative: Patient received vaccines on 6/7/11. Mom called on 6/8/11 and stated that the right thigh was red with approximately half dollar size around the inj. site.
Age: 14.0
Sex: F
Vaccine: HEPA, TYP
Symptoms: Activities of daily living impaired, Discomfort, Injection site swelling, Pain, Vaccination site pain
Clinical narrative: Rec'd vaccine on 6.8.11. Experienced slight discomfort at the time of administration which resolved. On 6.21.11, experienced moderate to severe pain in the left upper arm at the site of vaccination. On a scale from 1 -> 10 (least -> most), pain rated a (7) pain experienced with movement, such as raising arm, stretching and specifically noted with piano playing. States that she's unable to play DT the pain. Mother observes slight swelling at site. No redness/warmth.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site pain, Injection site rash, Injection site vesicles
Clinical narrative: Patient experienced an injection site rash & blisters. Also had a headache for most of the day following the administration of the ZOSTAVAX. She said the site burned.
Age: 64.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Rash vesicular
Clinical narrative: Having blisters/vesicles (+) shingle like symptoms a day after the injection.
Age: 56.0
Sex: F
Vaccine: HEPA, TTOX
Symptoms: Underdose
Clinical narrative: When administering HAVRIX the fluid leaked out of syringe and patient did not receive full dose. Called manufacturer and CDC and recommended give shot again. This was administered next day on 6/21/11.
Age: 11.0
Sex: U
Vaccine: HPV4, MNQ, TDAP
Symptoms: Erythema, Induration
Clinical narrative: Large area erythema with induration. Nontender palpation (R) deltoid.
Age: 19.0
Sex: F
Vaccine: VARCEL
Symptoms: Pruritus generalised
Clinical narrative: Very itchy all over body.
Age: 14.0
Sex: M
Vaccine: TYP, YF
Symptoms: Urticaria
Clinical narrative: Urticarial rash appeared June 11. Pt. self treated with BENADRYL. Switching to CLARITIN on 6/20/11.
Age: 70.0
Sex: M
Vaccine: HEP, HEPA, IPV, PPV
Symptoms: Chills, Erythema, Headache, Hyperaesthesia, Induration
Clinical narrative: 6-22-11 Below vaccines administered. 6-23-11 (R) lower arm (between shoulder & elbow) started to turn red & swell, sensitive to touch. Mild HA started - relieved with EXCEDRIN & chills. 6-24-11 Presented to health department w/above complaint (R) arm red, swollen, warm to touch 3 1/2 x 2 1/2" induration.
Age: 70.0
Sex: M
Vaccine: HEP, HEPA, IPV, PPV
Symptoms: Injection site erythema, Injection site swelling, Oedema peripheral, Skin warm
Clinical narrative: 6-22-11 Below vaccines administered. 6-23-11 (R) lower arm (between shoulder & elbow) started to turn red & swell, sensitive to touch. Mild HA started - relieved with EXCEDRIN & chills. 6-24-11 Presented to health department w/above complaint (R) arm red, swollen, warm to touch 3 1/2 x 2 1/2" induration.
Age: 62.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Erythema, Local reaction, Pain, Skin warm
Clinical narrative: (L) arm reaction redness, swelling, warmth PNEUMOVAX arm that had reaction. Localized reaction approx. 4 inches across & approx. 1 in wide. Pt continues to have soreness. Is using ice at 10-15 intervals will let us know if not improving by end business 6/24/11.
Age: 4.0
Sex: M
Vaccine: DTAP, MMR
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Rt. arm (deltoid) was swollen (2-3+), red, & hot to touch.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Influenza like illness, Injection site erythema, Injection site swelling, Injection site vesicles
Clinical narrative: Flu like systemic symptoms. Dark-red raised at injection site. Line of blisters from site on arm down to elbow.
Age: 63.0
Sex: M
Vaccine: PPV, TDAP
Symptoms: Chills, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Left upper arm swelling, redness & warmth of the whole upper arm pm after vaccine area approx size of plum. Was much larger per pt. 6/23/11 Slightly swollen, warm decreased redness. Pt continues to ice & using ADVIL for c/o chills - no temp. PNEUMOVAX arm had reaction.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Eczema
Clinical narrative: Eczematous rash on hands/feet 2 days after vaccine - no previous similar rash - Treated w/hydrocortisone 1% cream BID -> resolved.
Age: 35.0
Sex: M
Vaccine: MMR
Symptoms: Abdominal pain lower, Agitation, Anxiety, Nervousness, Pruritus
Clinical narrative: Face itching, especially around nose, kidney area moderate soreness, apprehension, agitation, general nervousness.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Chills, Head injury, Headache, Syncope, Unresponsive to stimuli
Clinical narrative: Patient was given HPV4 vaccine at around 3pm. She had been sitting looking through toy box and when she stood up, around 3:10pm, she collapsed, sat down on the floor and bumped back of head on counter. We helped patient to lie on the floor, until she responded to physicians calling her name (less than 1 minute). Vitals were pulse 60, BP was 100/74, finger stick BS 81. Thereafter, we helped pt to examining table, gave juice and granola bar. Vitals at 3:45pm, pulse 56, BP 92/60, temp 98.9 (complained of chills). Dr. did a re-evaluation of the patient. She also complained of headache. Physical exam was unremarkable which included exam of head. Left in care of mother, taken to car in wheelchair. To call or go to ER, if any significant neurological deficit, fever and anything concerning.
Age: 68.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash erythematous, Rash macular, Skin discomfort
Clinical narrative: Got shingles shot on 19th of May. About May 23rd I started getting small red bumps on my skin, by Jun 1st I had large red blotches in many places plus all the small red bumps. It is now Jun 22nd and they are just starting to leave. They did not hurt, but they were uncomfortable.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site rash, Rash, Rash macular
Clinical narrative: She has a rash on the entire back of left arm (smaller solid red area at site and blotchy on the rest) that after 5 days she reported was getting worse, so I recommended she contact her doctor.
Age: 24.0
Sex: F
Vaccine: TDAP
Symptoms: Dyspnoea, Rash
Clinical narrative: 6-17-11 awoke with rash. Took BENADRYL. On 6-19-11 developed difficulty breathing. Saw PCP on 6-20-11 & received cortisone injection & Prednisone po x 6 days.
Age: 18.0
Sex: F
Vaccine: HEPA, MNQ
Symptoms: Erythema, Fatigue, Headache, Injection site swelling, Pain of skin
Clinical narrative: Pt developed fever and headache tiredness. RA was swollen from collar bone to elbow. The skin was red & tender symptoms started at 7pm 6-9-11.
Age: 18.0
Sex: F
Vaccine: HEPA, MNQ
Symptoms: Pyrexia
Clinical narrative: Pt developed fever and headache tiredness. RA was swollen from collar bone to elbow. The skin was red & tender symptoms started at 7pm 6-9-11.
Age: 4.0
Sex: M
Vaccine: HEPA, PNC13
Symptoms: Injection site cellulitis, Injection site erythema, Injection site warmth
Clinical narrative: Two days after administration presented in clinic with cellulitis to injection site. Left thigh redness and warm to touch. Antibiotics given KEFLEX (250g/5ml) 5mL PO BID x 3 days.
Age: 37.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Rash
Clinical narrative: Rash to bilat arms. Moderate in nature.
Age: 1.38
Sex: M
Vaccine: DTAPIPVHIB, MMR, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Fever beginning 9-10 days following vaccine rash beginning day 13.
Age: 7.0
Sex: M
Vaccine: TYP
Symptoms: Chills, Pain, Pyrexia, Vomiting
Clinical narrative: Fever to 106 degrees, chills, one episode of vomiting, and local pain (probably LPS-related).
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pain in extremity
Clinical narrative: Possible cellulitis secondary to vaccination two days later was red & sore 1/2 way down to elbow got antibiotics from Dr.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Mobility decreased, Muscle spasms
Clinical narrative: The night of the vaccines her neck was turned all the way to the left and couldn't turn it to the right. She was seen in ER and told it was a neck spasm and was probably from the shots. She was given TYLENOL & was ok by the next day and no symptoms since.
Age: 1.0
Sex: M
Vaccine: DTAP, HEPA, HIBV, MMR, PNC, VARCEL
Symptoms: Ataxia, Depressed level of consciousness, Irritability, Laboratory test normal, Speech disorder
Clinical narrative: Altered sensorium (+) irritability, (+) decreased speech , (+) ataxia.
Age: 66.0
Sex: M
Vaccine: PPV, VARZOS
Symptoms: Injection site erythema, Injection site pain, Pain, Pyrexia
Clinical narrative: Pt was given both ZOSTAVAX and PNEUMOVAX 6-20-11. Approx 5 hrs later, developed generalized achiness, and right arm where ZOSTAVAX was given was sore and reddened. He had fever next day at 100.4 - 6/21 - seen by MD, Rx'ed anti-inflam, pt contacted 6/22 said improving.
Age: 0.2
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Rash papular
Clinical narrative: ELEVATED FLESH TONED PAPULES THROUGHOUT THE ENTIRE BODY